Chapter 1 Flashcards

Principles of Pharmacology (46 cards)

1
Q

Pharmacology

A

The scientific study of the actions of drugs and their effects on a living organism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neuropharmacology

A

Concerned with drug-induced changes in mood, thinking and behavior.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Goal of neuropsychopharmacology

A

To identify chemical substances that act on the nervous system to alter behavior that is disturbed because of injury, disease or environmental factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug Action

A

the specific molecular changes produced by a drug when it binds to a particular target site or receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drug effects

A

Molecular changes that lead to more widespread alterations in physiological or psychological functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Therapeutic effects

A

the drug-receptor interaction produces desired physical or behavioral changes. All other effects produced are referred to as side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Specific drug effects

A

those based on the physical and biochemical interactions of a drug with a target site in living tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Non specific drug effects

A

those that are based not on the chemical activity of a drug-receptor interaction, but on certain unique characteristics of the individual.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Placebo Effect

A

A pharmacologically inert compound administered to an individual; however in many instances it has not only therapeutic effects, but side effects as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nocebo Effect

A

Expecting treatment failure when an inert substance is given along with verbal suggestions of negative outcomes, such as increased pain or another aversive event, would increase anxiety as well as causing an accompanying change in neural mechanisms, including increases in stress hormones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

double-blind experiment

A

neither the patient nor the observer knows what treatment the participant has received.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

bioavailability

A

the amount of drug in the blood that is free to bind at specific target sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacokinetic

A

(1) route of administration
(2) absorption and distribution
(3) binding
(4) inactivation
(5) excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Routes of administration

A

How and where a drug is administered determines how quickly and how completely the drug is absorbed into the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Absorption and distribution

A

Because a drug rarely acts where it initially contacts the body, it must pass through a variety of cell membranes and enter the blood plasma, which transports the drug to virtually all of the cells in the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Binding

A

Once in the blood plasma, some drug molecules move to tissues to bind to active target sites (receptors). While in the blood, a drug may also bind (depot binding) to plasma proteins or may be stored temporarily in bone or fat, where it is inactive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Inactivation

A

Occurs primarily as a result of metabolic processes in the liver as well as other organs and tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Excretion

A

The liver metabolites are eliminated from the body with the urine or feces. Some drugs are excreted in an unaltered form by the kidneys.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Enteral methods

A

Use the GI tract

20
Q

Parenteral

A

those that do not include the use of the alimentary canal, such as injection, pulmonary, and topical

21
Q

First pass metabolism

A

potentially harmful chemicals and toxins that are ingested pass via the portal vein to the liver, where they are chemically altered by a variety of enzymes before passing to the heart for circulation throughout the body

22
Q

Absorption

A

movement of the drug from the site of administration to the blood circulation

23
Q

gene therapy

A

the application of DNA which encodes a specific protein, to a particular target site.

24
Q

Phospolipids

A

complex lipid (fat) molecules that make up cell membranes

25
Passive diffusion
Drugs with high lipid solubility move through the cell membranes by passive diffusion, leaving the water in the blood or stomach juices and entering the lipid layers of membranes.
26
Concentration gradient
The larger the concentration difference on each side of the membrane, the more rapid is the diffusion.
27
Bioactivation
A drug that is dependent on metabolism to convert an inactive drug to an active one.
28
Receptor agonists
Lock and key suggests that only a limited group of neurochemicals or drugs can bind to a particular receptor protein to initiate a cellular response
29
Affinity
best chemical fit
30
Receptor antagonists
not only do they produce no cellular effect after binding, but by binding to the receptor, they prevent an "active" ligand from binding; hence they "block" the receptor
31
Partial agonists
demonstrate efficacy that is less than that of full agonists but more than that of an antagonist at a given receptor
32
Inverse agonists
when they bind to a receptor, they initiate a biological action, but it is an action that is opposite to that produced by an agonist.
33
Dose-response curve
Describes the extent of biological or behavioral effect produced by a given drug concentration.
34
Potency
The absolute amount of drug necessary to produce a specific effect.
35
therapeutic index
calculated by comparing the dose of drug required to produce a toxic effect in 50% of individuals with the dose that is effective for 50%.
36
Competitive antagonists
Those drugs that compete with agonists to bind to receptors but fail to initiate an intracellular effect, thereby reducing the effects of the agonists.
37
Noncompetitive antagonists
drugs that reduce the effects of agonists in ways other than competing for the receptor
38
Physiological antagonism
involves two drugs that act in two distinct ways but interact in such a way that they reduce each other's effectiveness in the body
39
additive effects
outcome of both meds exceeds the effect of either drug alone
40
potentiation
situation in which the combination of two drugs produces the effects that are greater than the sum of their individual effects
41
tolerance
diminished response to drug administration after repeated exposure to that drug
42
cross-tolerance
development of tolerance to one drug can diminish the effectiveness of a second drug
43
Acute tolerance
tolerance develops during just a single administration
44
Pharmacodynamic tolerance
occurs when changes in never cell function compensate for continued presence of the drug
45
Operant conditioning
the appearance of tolerance to a psychoactive drug
46
Sensitization
the enhancement of particular drug effects after repeated administration of the same dose of the drug